Evolving Story of Clinical Trials in Hypertrophic Cardiomyopathy

被引：6
作者：
Elliott, Perry M. [1 ,2 ]
机构：
[1] UCL, St Bartholomews Hosp, London, England
[2] UCL, Inst Cardiovasc Sci, London, England
来源：
CIRCULATION-HEART FAILURE | 2018年 / 11卷 / 01期
关键词：
Editorials; cardiomyopathy; hypertrophic; myocytes; cardiac; ranolazine;
D O I：
10.1161/CIRCHEARTFAILURE.117.004572
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 7 条
  • [1] Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial
    Axelsson, Anna
    Iversen, Kasper
    Vejlstrup, Niels
    Ho, Carolyn
    Norsk, Jakob
    Langhoff, Lasse
    Ahtarovski, Kiril
    Corell, Pernille
    Havndrup, Ole
    Jensen, Morten
    Bundgaard, Henning
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (02) : 123 - 131
  • [2] A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure
    Cahalin, Lawrence P.
    Chase, Paul
    Arena, Ross
    Myers, Jonathan
    Bensimhon, Daniel
    Peberdy, Mary Ann
    Ashley, Euan
    West, Erin
    Forman, Daniel E.
    Pinkstaff, Sherry
    Lavie, Carl J.
    Guazzi, Marco
    [J]. HEART FAILURE REVIEWS, 2013, 18 (01) : 79 - 94
  • [3] Cardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy
    Coats, Caroline J.
    Rantell, Khadija
    Bartnik, Aleksandra
    Patel, Amour
    Mist, Bryan
    McKenna, William J.
    Elliott, Perry M.
    [J]. CIRCULATION-HEART FAILURE, 2015, 8 (06) : 1022 - 1031
  • [4] Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy
    Coppini, Raffaele
    Ferrantini, Cecilia
    Yao, Lina
    Fan, Peidong
    Del Lungo, Martina
    Stillitano, Francesca
    Sartiani, Laura
    Tosi, Benedetta
    Suffredini, Silvia
    Tesi, Chiara
    Yacoub, Magdi
    Olivotto, Iacopo
    Belardinelli, Luiz
    Poggesi, Corrado
    Cerbai, Elisabetta
    Mugelli, Alessandro
    [J]. CIRCULATION, 2013, 127 (05) : 575 - +
  • [5] 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
    Elliott, Perry M.
    Anastasakis, Aris
    Borger, Michael A.
    Borggrefe, Martin
    Cecchi, Franco
    Charron, Philippe
    Hagege, Albert Alain
    Lafont, Antoine
    Limongelli, Giuseppe
    Mahrholdt, Heiko
    McKenna, William J.
    Mogensen, Jens
    Nihoyannopoulos, Petros
    Nistri, Stefano
    Pieper, Petronella G.
    Pieske, Burkert
    Rapezzi, Claudio
    Rutten, Frans H.
    Tillmanns, Christoph
    Watkins, Hugh
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (39) : 2733 - +
  • [6] A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)
    O'Mahony, Constantinos
    Jichi, Fatima
    Pavlou, Menelaos
    Monserrat, Lorenzo
    Anastasakis, Aristides
    Rapezzi, Claudio
    Biagini, Elena
    Ramon Gimeno, Juan
    Limongelli, Giuseppe
    McKenna, William J.
    Omar, Rumana Z.
    Elliott, Perry M.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (30) : 2010 - +
  • [7] Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study
    Olivotto, Iacopo
    Camici, Paolo G.
    Merlini, Piera Angelica
    Rapezzi, Claudio
    Patten, Monica
    Climent, Vicent
    Sinagra, Gianfranco
    Tomberli, Benedetta
    Marin, Francisco
    Ehlermann, Philipp
    Maier, Lars S.
    Fornaro, Alessandra
    Jacobshagen, Claudius
    Ganau, Antonello
    Moretti, Luciano
    Hernandez Madrid, Antonio
    Coppini, Raffaele
    Reggiardo, Giorgio
    Poggesi, Corrado
    Fattirolli, Francesco
    Belardinelli, Luiz
    Gensini, Gianfranco
    Mugelli, Alessandro
    [J]. CIRCULATION-HEART FAILURE, 2018, 11 (01) : e004124
1